|
|
||||||||
CUTTING EDGE |

* Department of Microbiology and Immunology, Dartmouth Medical School and Norris Cotton Cancer Center, Lebanon, NH 03756; and
Department of Experimental Pathology, Institute for Frontier Medical Sciences, and Department of Transplantation and Immunology, Faculty of Medicine, Kyoto University, Kyoto, Japan
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
secretion (3). Similarly, a TGF-
-dependent mechanism has also been implicated in suppression by CD4+CD25+ Treg (4, 5, 6). In addition to suppression via soluble factors, the CD4+CD25+ Treg have been shown to mediate suppression via a contact-dependent mechanism (7). The molecular basis for contact-dependent suppression by CD4+CD25+ Treg is not known. Glucocorticoid-induced TNF-like receptor (GITR or TNFSF18) is a member of the TNFR family that is constitutively expressed on Treg and inducibly expressed on CD4+CD25 effector T cells (Teff) (8, 9). Triggering of GITR has been shown to extinguish their contact-dependent suppressive activity (8, 10). Based on this overt change in biological function, transcriptional profiling of resting, activated Treg, and anti-GITR-treated activated Treg has led to the identification of a number of candidate molecules that may be involved in contact-dependent suppression. One such molecule that was identified as up-regulated in activated Treg and whose expression was reduced via GITR-triggering is granzyme B (GZ-B).
GZ-B is a serine protease, secreted mainly by NK cells and CTLs (11), and is largely responsible for the induction of apoptosis in the target cell. However, recent reports have shown that human CD4+ T cells are also able to synthesize GZ-B and perforin (12, 13). Furthermore, studies by Ley and coworkers as well as others (14, 15) have shown that GZ-B is highly up-regulated in activated human T cells bearing a Tr1 phenotype. Moreover, Ley and coworkers (16) have shown CD4+CD25+ Treg in the human system mediate suppression with requirement for granzyme A (GZ-A). These results suggest a possible role for granzyme in mediating T cell suppression. The data presented in this study implicate that GZ-B plays a pivotal role in the suppressive capacity of murine CD4+CD25+ Treg.
| Materials and Methods |
|---|
|
|
|---|
Congenic strains CD45.1 or CD45.2 C57BL/6 and perforin/ mice, 810 wk old, were purchased from The Jackson Laboratory. C57BL/6 GZ-B/ mice (15) were bred and maintained in our facility at Dartmouth Medical School.
Cell isolation, gene array, and real time
Single-cell suspensions were prepared from 8- to 10-wk-old mice and applied to CD4 enrichment. CD4+CD25 and CD4+CD25+ T cells were further purified by magnetic separation with MACS (Miltenyi Biotec) according to the manufacturers instructions. Enriched cell populations and purified cells were phenotypically analyzed by FACS. The purities of CD4+CD25 and CD4+CD25+ T cells were 9095%, respectively. Freshly isolated cells have been inoculated (106/ml; complete RPMI 1640/10% FBS supplemented with 100 U of IL2) into a 24-well plate precoated with 10 µg/ml anti-CD3 (clone 2C11) with or without 10 µg/ml anti-GITR (clone DTA-1; Ref.8) cultured at 37°C for 0, 12, and 48 h. Purified RNA were then analyzed by using Affymetrix mouse genome A430 oligonucleotide arrays or by real-time PCR analysis.
Cell culture and T cell suppression assay
GZ-B expression was assessed in freshly isolated CD4+CD25+ T cells or in cells cultured in vitro 2472 h in the presence of plate-bound CD3 (1 µg/ml) with 100 U/ml IL-2.
Spleens and lymph nodes from wild-type, perforin/, or GZ-B/ mice were magnetic bead sorted as stated above. Further purification of the Teff subset was accomplished with a CD4+ T cell Isolation kit (Miltenyi Biotec). Effector cells were >95% pure at the end of this isolation. In a polyclonal Treg suppressor assay, CD4+CD25 Teff cells (5 x 104) were cocultured with irradiated T-depleted splenocytes (1 x 105), 5 µg/ml anti-CD3, and indicated numbers of CD4+CD25+ cells for 3 days. In some experiments, 5 µg/ml anti-GITR was also added to the wells. Proliferation was assessed by incorporation of [3H]thymidine (1 µCi/well), which was added for the last 8 h of culture.
Cell surface, intracellular staining, and flow cytometry
Approximately 2 x 105 cells from each of triplicate wells were collected and pooled. Cells were labeled with anti-CD45.1-allophycocyanin (clone A20; eBioscience). Samples were then resuspended in 1x annexin staining buffer and treated with Annexin VFITC (BD Pharmingen) and propidium iodide (PI; Sigma-Aldrich). For GZ-B expression assay, following isolation for fresh Treg or 2472 h for cultured Treg, cells were stained with anti-CD4-FITC (clone RM 4-5) and anti-CD25-PE (clone PC-61). Samples were then fixed and permeabilized (Cytofix/Cytoperm; BD Pharmingen) and stained with anti-human GZ-B-allophycocyanin (clone GB12; Caltag) diluted 1/200 in staining buffer. Throughout all steps, normal rat serum (5% v/v; Invitrogen Life Technologies) was used to block nonspecific binding. Samples were analyzed on FACScan (BD Biosciences). Anti-human GZ-B cross-reactivity with mouse GZ-B has been previously reported (15). For CFSE experiments, CD45.1+ cells were labeled with 5 µM CFSE and added to suppressor assay as described above.
Statistical analysis
Analysis of proliferation assays and real-time expression between the various treatment groups were analyzed by two-tailed, paired Students t test. Values of p < 0.05 were considered significant.
| Results and Discussion |
|---|
|
|
|---|
CD4+CD25+ Treg are suppressive to naive CD4+ Teff in vitro following polyclonal and Ag-specific activation. Furthermore, the in vitro suppressive capacity has been shown to be contact dependent and ablated following treatment with anti-GITR (8). Global gene analysis of activated Treg treated or untreated with anti-GITR was used to identify candidate genes involved in suppression. We examined naive and activated Teff (purified CD4+CD25 T cells) and Treg (purified CD4+CD25+ T cells) in the presence of anti-CD3 with or without anti-GITR for 12 or 48 h. Of the
22,700 genes examined, 259 were up-regulated >1.5-fold and 99 were down-regulated >1.5-fold in Treg following treatment with anti-GITR and anti-CD3 relative to treatment with anti-CD3 alone. GZ-B, as has been shown previously, is up-regulated with Treg activation via anti-CD3 alone (9, 17). Studies presented herein show that that GZ-B is down-regulated 2-fold with anti-CD3 in combination with anti-GITR (Fig. 1, A and B). The microarray data was confirmed by RT-PCR (Fig. 1C). At both the 12- and 48-h time point, the levels GZ-B expression are 2-fold greater with anti-CD3 alone treatment vs combining with anti-GITR stimulation. Moreover, protein expression of GZ-B recapitulates the results found via RT-PCR by increasing the abundance of GZ-B from 24 to 72 h (Fig. 1D). Additionally, after 12 h in culture, Treg GZ-B mRNA expression is 20-fold greater than Teff with CD3 stimulation alone (data not shown). We also examined expression levels of GZ-A and perforin at all time points. For both molecules, we see similar regulation to that of GZ-B with anti-GITR treatment; however, expression is at a much lower intensity at all time points (Fig. 1, A and B). These data were also confirmed by RT-PCR (data not shown). These data indicate that, immediately following activation, Treg rapidly up-regulate GZ-B; however, GZ-A and perforin remain low in abundance relative to GZ-B expression.
|
Coculture of Treg with wild-type Teff leads to suppression of proliferation in a dose-dependent manner. To functionally evaluate the role of GZ-B in the contact-mediated suppression by Treg, the suppressive activity of Treg from WT and GZ-B/ mice was compared (Fig. 2A). Data presented show that Treg from WT mice at a 1:1 ratio suppress the proliferation of Teff >90%, whereas Treg from GZ-B/ mice suppress Teff proliferation <50%. The reduced suppressive activity of Treg from GZ-B/ mice is observed across a spectrum of Treg:Teff ratios, suggesting a functional role of GZ-B in contact-mediated suppression. A comparison of FoxP3 levels of GZ-B/ Treg revealed no significant difference from those of WT Treg (data not shown). Because loss of GZ-B does not completely extinguish Treg suppression, additional contact-dependent mechanisms must be important in this system.
|
A recent report by Grossman et al. (16) indicates that human CD4+CD25+ Treg mediate their suppressive effects via death induced by a GZ-A perforin-dependent mechanism. The differences between the use of GZ-A in humans and GZ-B in mice could be due to species differences, or subtle differences in the subsets and/or activation of T cells that were used. With regard to perforin dependency, the study by Ley (16) implicates perforin because of the fact that a calcium chelator relieves suppression. Although this is a reasonable assertion, they also show that CD18 is required, and it is known that this molecule requires calcium to form the tight synapse required for granzyme-mediated toxicity (23, 24, 25). In our studies using perforin knockout mice, suppression was indistinguishable from WT mice.
Induction of Teff apoptosis is a component of contact-mediated suppression
Recent reports have re-examined apoptosis by Treg of Teff as a mechanism for suppression (15, 26). The molecule(s) that mediate the induction of Teff apoptosis have not been resolved, and it is unlikely that FasL plays a central role (27). Based on the finding that GZ-B plays a functionally significant role in Treg suppression, the ability of Treg to induce Teff apoptosis and cell death was re-examined. The induction of Teff apoptosis by Treg was determined following the in vitro coculture of activated Teff and Treg. Briefly, CD45.1+ (Ly5.2+) Teff were cocultured with increasing numbers of CD45.2+ (Ly5.1+) Treg, in the presence of anti-CD3. After 72 h of culture, apoptosis of the CD4+ Teff was determined by multiparameter flow cytometry. The data show that there is a dose-dependent increase in cell death of the Teff cells when cocultured with Treg, such that
50% more Teff are dead at a 1:1 ratio than at a 1:16 ratio of Treg to Teff (Fig. 3A). Moreover, addition of anti-GITR relieves the suppression and apoptosis as evidenced by enhanced proliferation and cell survival (data not shown). In parallel experiments, we examined thymidine incorporation in a standard suppressor assay with Treg from wild-type mice treated with anti-CD3 to determine levels of suppressive activity concurrent with PI/annexin staining (Fig. 3B). To distinguish between the antiproliferative and antiapoptotic effect of Treg, we examined suppression and death with CFSE-labeled Teff counterstained with PI. In Fig. 3C, we demonstrate that the Teff have a greater percentage of PI+ cells when cocultured with Treg. Interestingly, in addition to the induction of cell death, the proliferation of PI Teff was also inhibited, which indicates multiple mechanisms are involved in Treg-mediated suppression.
|
| Footnotes |
|---|
1 This work was supported by National Institutes of Health Grants CA91436-01 and AI48667. ![]()
2 D.C.G. and L.-F.L. contributed equally to this manuscript. ![]()
3 Address correspondence and reprint requests to Dr. Randolph J. Noelle, Department of Microbiology and Immunology, Norris Cotton Cancer Center, Dartmouth Hitchcock Medical Center, Dartmouth Medical School, 1 Medical Center Drive, Lebanon, NH 03756. E-mail address: rjn{at}dartmouth.edu ![]()
4 Abbreviations used in this paper: Treg, regulatory T cell; Teff, effector T cell; GITR, glucocorticoid-induced TNF-like receptor; GZ-B, granzyme B; GZ-A, granzyme A; PI, propidium iodide. ![]()
Received for publication August 18, 2004. Accepted for publication December 7, 2004.
| References |
|---|
|
|
|---|
. J. Exp. Med. 194:629.
1 production and responsiveness. J. Exp. Med. 196:237.
1 plays an important role in the mechanism of CD4+CD25+ regulatory T cell activity in both humans and mice. J. Immunol. 172:834.This article has been cited by other articles:
![]() |
X. Cao, K. Leonard, L. I. Collins, S. F. Cai, J. C. Mayer, J. E. Payton, M. J. Walter, D. Piwnica-Worms, R. D. Schreiber, and T. J. Ley Interleukin 12 Stimulates IFN-{gamma}-Mediated Inhibition of Tumor-Induced Regulatory T-Cell Proliferation and Enhances Tumor Clearance Cancer Res., November 15, 2009; 69(22): 8700 - 8709. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. W. Ashley and C. Baecher-Allan Cutting Edge: Responder T Cells Regulate Human DR+ Effector Regulatory T Cell Activity via Granzyme B J. Immunol., October 15, 2009; 183(8): 4843 - 4847. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sakaguchi, K. Wing, Y. Onishi, P. Prieto-Martin, and T. Yamaguchi Regulatory T cells: how do they suppress immune responses? Int. Immunol., October 1, 2009; 21(10): 1105 - 1111. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Petrausch, S. M. Jensen, C. Twitty, C. H. Poehlein, D. P. Haley, E. B. Walker, and B. A. Fox Disruption of TGF-{beta} Signaling Prevents the Generation of Tumor-Sensitized Regulatory T Cells and Facilitates Therapeutic Antitumor Immunity J. Immunol., September 15, 2009; 183(6): 3682 - 3689. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. A. Forward, S. J. Furlong, Y. Yang, T.-J. Lin, and D. W. Hoskin Mast Cells Down-Regulate CD4+CD25+ T Regulatory Cell Suppressor Function via Histamine H1 Receptor Interaction J. Immunol., September 1, 2009; 183(5): 3014 - 3022. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hagn, E. Schwesinger, V. Ebel, K. Sontheimer, J. Maier, T. Beyer, T. Syrovets, Y. Laumonnier, D. Fabricius, T. Simmet, et al. Human B Cells Secrete Granzyme B When Recognizing Viral Antigens in the Context of the Acute Phase Cytokine IL-21 J. Immunol., August 1, 2009; 183(3): 1838 - 1845. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Ngan, S. V. Vickerman, D. J. Granville, S. F. P. Man, and D. D. Sin The possible role of granzyme B in the pathogenesis of chronic obstructive pulmonary disease Therapeutic Advances in Respiratory Disease, June 1, 2009; 3(3): 113 - 129. [Abstract] [PDF] |
||||
![]() |
A. L. Szymczak-Workman, C. J. Workman, and D. A. A. Vignali Cutting Edge: Regulatory T Cells Do Not Require Stimulation through Their TCR to Suppress J. Immunol., May 1, 2009; 182(9): 5188 - 5192. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Freishtat, J. Natale, A. S. Benton, J. Cohen, M. Sharron, A. A. Wiles, W.-M. Ngor, B. Mojgani, M. Bradbury, A. Degnan, et al. Sepsis Alters the Megakaryocyte-Platelet Transcriptional Axis Resulting in Granzyme B-mediated Lymphotoxicity Am. J. Respir. Crit. Care Med., March 15, 2009; 179(6): 467 - 473. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Strauss, C. Bergmann, and T. L. Whiteside Human Circulating CD4+CD25highFoxp3+ Regulatory T Cells Kill Autologous CD8+ but Not CD4+ Responder Cells by Fas-Mediated Apoptosis J. Immunol., February 1, 2009; 182(3): 1469 - 1480. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. O. Alpdogan, S. X. Lu, N. Patel, S. McGoldrick, D. Suh, T. Budak-Alpdogan, O. M. Smith, J. Grubin, C. King, G. L. Goldberg, et al. Rapidly proliferating CD44hi peripheral T cells undergo apoptosis and delay posttransplantation T-cell reconstitution after allogeneic bone marrow transplantation Blood, December 1, 2008; 112(12): 4755 - 4764. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Gondek, V. DeVries, E. C. Nowak, L.-F. Lu, K. A. Bennett, Z. A. Scott, and R. J. Noelle Transplantation Survival Is Maintained by Granzyme B+ Regulatory Cells and Adaptive Regulatory T Cells J. Immunol., October 1, 2008; 181(7): 4752 - 4760. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ota, M. Aoki-Ota, K. Tsunoda, T. Nishikawa, S. Koyasu, and M. Amagai Autoreactive B-cell elimination by pathogenic IgG specific for the same antigen: implications for peripheral tolerance Int. Immunol., October 1, 2008; 20(10): 1351 - 1360. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. B. Marshall, W. R. Vorachek, L. B. Steppan, D. V. Mourich, and N. I. Kerkvliet Functional Characterization and Gene Expression Analysis of CD4+CD25+ Regulatory T Cells Generated in Mice Treated with 2,3,7,8-Tetrachlorodibenzo-p-Dioxin J. Immunol., August 15, 2008; 181(4): 2382 - 2391. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Lehe, H. Ghebeh, A. Al-Sulaiman, G. Al Qudaihi, K. Al-Hussein, F. Almohareb, N. Chaudhri, F. Alsharif, H. Al-Zahrani, A. Tbakhi, et al. The Wilms' Tumor Antigen Is a Novel Target for Human CD4+ Regulatory T Cells: Implications for Immunotherapy Cancer Res., August 1, 2008; 68(15): 6350 - 6359. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Djoba Siawaya, N. B. Bapela, K. Ronacher, N. Beyers, P. van Helden, and G. Walzl Differential Expression of Interleukin-4 (IL-4) and IL-4{delta}2 mRNA, but Not Transforming Growth Factor Beta (TGF-{beta}), TGF-{beta}RII, Foxp3, Gamma Interferon, T-bet, or GATA-3 mRNA, in Patients with Fast and Slow Responses to Antituberculosis Treatment Clin. Vaccine Immunol., August 1, 2008; 15(8): 1165 - 1170. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Lages, I. Suffia, P. A. Velilla, B. Huang, G. Warshaw, D. A. Hildeman, Y. Belkaid, and C. Chougnet Functional Regulatory T Cells Accumulate in Aged Hosts and Promote Chronic Infectious Disease Reactivation J. Immunol., August 1, 2008; 181(3): 1835 - 1848. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Onishi, Z. Fehervari, T. Yamaguchi, and S. Sakaguchi Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation PNAS, July 22, 2008; 105(29): 10113 - 10118. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. F. Lind, C. L. Ahonen, A. Wasiuk, Y. Kosaka, B. Becher, K. A. Bennett, and R. J. Noelle Dendritic Cells Require the NF-{kappa}B2 Pathway for Cross-Presentation of Soluble Antigens J. Immunol., July 1, 2008; 181(1): 354 - 363. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Carvalho-Gaspar, N. D. Jones, S. Luo, L. Martin, M. O. Brook, and K. J. Wood Location and Time-Dependent Control of Rejection by Regulatory T Cells Culminates in a Failure to Generate Memory T Cells J. Immunol., May 15, 2008; 180(10): 6640 - 6648. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. L. Stevenson, E. C. Crossley, N. Thirumalapura, D. H. Walker, and N. Ismail Regulatory Roles of CD1d-Restricted NKT Cells in the Induction of Toxic Shock-Like Syndrome in an Animal Model of Fatal Ehrlichiosis Infect. Immun., April 1, 2008; 76(4): 1434 - 1444. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Gosink, H. T. Petrie, and N. F. Tsinoremas Electronically subtracting expression patterns from a mixed cell population Bioinformatics, December 15, 2007; 23(24): 3328 - 3334. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Yang, M. O. Brook, M. Carvalho-Gaspar, J. Zhang, H. E. Ramon, M. H. Sayegh, K. J. Wood, L. A. Turka, and N. D. Jones Allograft rejection mediated by memory T cells is resistant to regulation PNAS, December 11, 2007; 104(50): 19954 - 19959. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Hubert, N. Jacobs, J.-H. Caberg, J. Boniver, and P. Delvenne The cross-talk between dendritic and regulatory T cells: good or evil? J. Leukoc. Biol., October 1, 2007; 82(4): 781 - 794. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. DiPaolo, C. Brinster, T. S. Davidson, J. Andersson, D. Glass, and E. M. Shevach Autoantigen-Specific TGFbeta-Induced Foxp3+ Regulatory T Cells Prevent Autoimmunity by Inhibiting Dendritic Cells from Activating Autoreactive T Cells J. Immunol., October 1, 2007; 179(7): 4685 - 4693. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Oberle, N. Eberhardt, C. S. Falk, P. H. Krammer, and E. Suri-Payer Rapid Suppression of Cytokine Transcription in Human CD4+CD25 T Cells by CD4+Foxp3+ Regulatory T Cells: Independence of IL-2 Consumption, TGF-beta, and Various Inhibitors of TCR Signaling J. Immunol., September 15, 2007; 179(6): 3578 - 3587. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Guilliams, G. Oldenhove, W. Noel, M. Herin, L. Brys, P. Loi, V. Flamand, M. Moser, P. De Baetselier, and A. Beschin African Trypanosomiasis: Naturally Occurring Regulatory T Cells Favor Trypanotolerance by Limiting Pathology Associated with Sustained Type 1 Inflammation J. Immunol., September 1, 2007; 179(5): 2748 - 2757. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. N. Beilke and R. G. Gill Frontiers in Nephrology: The Varied Faces of Natural Killer Cells in Transplantation Contributions to Both Allograft Immunity and Tolerance J. Am. Soc. Nephrol., August 1, 2007; 18(8): 2262 - 2267. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Billerbeck, H. E. Blum, and R. Thimme Parallel Expansion of Human Virus-Specific FoxP3- Effector Memory and De Novo-Generated FoxP3+ Regulatory CD8+ T Cells upon Antigen Recognition In Vitro J. Immunol., July 15, 2007; 179(2): 1039 - 1048. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E.A. Street, N. Zerafa, M. Iezzi, J. A. Westwood, J. Stagg, P. Musiani, and M. J. Smyth Host Perforin Reduces Tumor Number but Does Not Increase Survival in Oncogene-Driven Mammary Adenocarcinoma Cancer Res., June 1, 2007; 67(11): 5454 - 5460. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. G. Elpek, C. Lacelle, N. P. Singh, E. S. Yolcu, and H. Shirwan CD4+CD25+ T Regulatory Cells Dominate Multiple Immune Evasion Mechanisms in Early but Not Late Phases of Tumor Development in a B Cell Lymphoma Model J. Immunol., June 1, 2007; 178(11): 6840 - 6848. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Baatar, P. Olkhanud, K. Sumitomo, D. Taub, R. Gress, and A. Biragyn Human Peripheral Blood T Regulatory Cells (Tregs), Functionally Primed CCR4+ Tregs and Unprimed CCR4- Tregs, Regulate Effector T Cells Using FasL J. Immunol., April 15, 2007; 178(8): 4891 - 4900. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Marinova, S. Han, and B. Zheng Germinal Center Helper T Cells Are Dual Functional Regulatory Cells with Suppressive Activity to Conventional CD4+ T Cells J. Immunol., April 15, 2007; 178(8): 5010 - 5017. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Rudge, S. P. Barrett, B. Scott, and I. R. van Driel Infiltration of a Mesothelioma by IFN-{gamma}-Producing Cells and Tumor Rejection after Depletion of Regulatory T Cells J. Immunol., April 1, 2007; 178(7): 4089 - 4096. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Haribhai, W. Lin, L. M. Relland, N. Truong, C. B. Williams, and T. A. Chatila Regulatory T Cells Dynamically Control the Primary Immune Response to Foreign Antigen J. Immunol., March 1, 2007; 178(5): 2961 - 2972. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. K. Crellin, R. V. Garcia, and M. K. Levings Altered activation of AKT is required for the suppressive function of human CD4+CD25+ T regulatory cells Blood, March 1, 2007; 109(5): 2014 - 2022. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Zeiser, V. H. Nguyen, J.-Z. Hou, A. Beilhack, E. Zambricki, M. Buess, C. H. Contag, and R. S. Negrin Early CD30 signaling is critical for adoptively transferred CD4+CD25+ regulatory T cells in prevention of acute graft-versus-host disease Blood, March 1, 2007; 109(5): 2225 - 2233. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Marangoni, S. Trifari, S. Scaramuzza, C. Panaroni, S. Martino, L. D. Notarangelo, Z. Baz, A. Metin, F. Cattaneo, A. Villa, et al. WASP regulates suppressor activity of human and murine CD4+CD25+FOXP3+ natural regulatory T cells J. Exp. Med., February 19, 2007; 204(2): 369 - 380. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-X. Zhang, Y. Ma, H. Wang, J. Arp, J. Jiang, X. Huang, K. M. He, B. Garcia, J. Madrenas, and R. Zhong Double-Negative T Cells, Activated by Xenoantigen, Lyse Autologous B and T Cells Using a Perforin/Granzyme-Dependent, Fas-Fas Ligand-Independent Pathway J. Immunol., November 15, 2006; 177(10): 6920 - 6929. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Sukiennicki and D. J. Fowell Distinct Molecular Program Imposed on CD4+ T Cell Targets by CD4+CD25+ Regulatory T Cells J. Immunol., November 15, 2006; 177(10): 6952 - 6961. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Lewkowicz, N. Lewkowicz, A. Sasiak, and H. Tchorzewski Lipopolysaccharide-Activated CD4+CD25+ T Regulatory Cells Inhibit Neutrophil Function and Promote Their Apoptosis and Death J. Immunol., November 15, 2006; 177(10): 7155 - 7163. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Venet, A. Pachot, A.-L. Debard, J. Bohe, J. Bienvenu, A. Lepape, W. S. Powell, and G. Monneret Human CD4+CD25+ Regulatory T Lymphocytes Inhibit Lipopolysaccharide-Induced Monocyte Survival through a Fas/Fas Ligand-Dependent Mechanism J. Immunol., November 1, 2006; 177(9): 6540 - 6547. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Steffens, F. Burger, G. Pelli, Y. Dean, G. Elson, M. Kosco-Vilbois, L. Chatenoud, and F. Mach Short-Term Treatment With Anti-CD3 Antibody Reduces the Development and Progression of Atherosclerosis in Mice Circulation, October 31, 2006; 114(18): 1977 - 1984. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Reibke, N. Garbi, R. Ganss, G. J. Hammerling, B. Arnold, and T. Oelert CD8+ regulatory T cells generated by neonatal recognition of peripheral self-antigen PNAS, October 10, 2006; 103(41): 15142 - 15147. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Tschopp, N. Spiegl, S. Didichenko, W. Lutmann, P. Julius, J. C. Virchow, C. E. Hack, and C. A. Dahinden Granzyme B, a novel mediator of allergic inflammation: its induction and release in blood basophils and human asthma Blood, October 1, 2006; 108(7): 2290 - 2299. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Loser and S. Beissert Therapeutic modulation of cutaneous autoimmunity by regulatory T cells Rheumatology, October 1, 2006; 45(suppl_3): iii20 - iii22. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Toda and C. A. Piccirillo Development and function of naturally occurring CD4+CD25+ regulatory T cells J. Leukoc. Biol., September 1, 2006; 80(3): 458 - 470. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Uss, A. T. Rowshani, B. Hooibrink, N. M. Lardy, R. A. W. van Lier, and I. J. M. ten Berge CD103 Is a Marker for Alloantigen-Induced Regulatory CD8+ T Cells. J. Immunol., September 1, 2006; 177(5): 2775 - 2783. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Sugimoto, T. Oida, K. Hirota, K. Nakamura, T. Nomura, T. Uchiyama, and S. Sakaguchi Foxp3-dependent and -independent molecules specific for CD25+CD4+ natural regulatory T cells revealed by DNA microarray analysis Int. Immunol., August 1, 2006; 18(8): 1197 - 1209. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Wing, Z. Fehervari, and S. Sakaguchi Emerging possibilities in the development and function of regulatory T cells Int. Immunol., July 1, 2006; 18(7): 991 - 1000. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-Y. Qin, R. Mukherjee, E. Lee-Chan, C. Ewen, R. C. Bleackley, and B. Singh A novel mechanism of regulatory T cell-mediated down-regulation of autoimmunity Int. Immunol., July 1, 2006; 18(7): 1001 - 1015. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sumoza-Toledo, A. D. Eaton, and A. Sarukhan Regulatory T Cells Inhibit Protein Kinase C{theta} Recruitment to the Immune Synapse of Naive T Cells with the Same Antigen Specificity J. Immunol., May 15, 2006; 176(10): 5779 - 5787. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-M. Zhao, A. M. Thornton, R. J. DiPaolo, and E. M. Shevach Activated CD4+CD25+ T cells selectively kill B lymphocytes Blood, May 15, 2006; 107(10): 3925 - 3932. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Antony, C. M. Paulos, M. Ahmadzadeh, A. Akpinarli, D. C. Palmer, N. Sato, A. Kaiser, C. Heinrichs, C. A. Klebanoff, Y. Tagaya, et al. Interleukin-2-Dependent Mechanisms of Tolerance and Immunity In Vivo J. Immunol., May 1, 2006; 176(9): 5255 - 5266. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Neujahr, C. Chen, X. Huang, J. F. Markmann, S. Cobbold, H. Waldmann, M. H. Sayegh, W. W. Hancock, and L. A. Turka Accelerated Memory Cell Homeostasis during T Cell Depletion and Approaches to Overcome It. J. Immunol., April 15, 2006; 176(8): 4632 - 4639. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Weber, J. Harbertson, E. Godebu, G. A. Mros, R. C. Padrick, B. D. Carson, S. F. Ziegler, and L. M. Bradley Adaptive islet-specific regulatory CD4 T cells control autoimmune diabetes and mediate the disappearance of pathogenic Th1 cells in vivo. J. Immunol., April 15, 2006; 176(8): 4730 - 4739. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Chen, N. Zhang, S. Fu, B. Schroppel, Q. Guo, A. Garin, S. A. Lira, and J. S. Bromberg CD4+CD25+ Regulatory T-Cells Inhibit the Islet Innate Immune Response and Promote Islet Engraftment. Diabetes, April 1, 2006; 55(4): 1011 - 1021. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Pace, S. Rizzo, C. Palombi, F. Brombacher, and G. Doria Cutting Edge: IL-4-Induced Protection of CD4+CD25- Th Cells from CD4+CD25+ Regulatory T Cell-Mediated Suppression J. Immunol., April 1, 2006; 176(7): 3900 - 3904. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Laforge, N. Bidere, S. Carmona, A. Devocelle, B. Charpentier, and A. Senik Apoptotic Death Concurrent with CD3 Stimulation in Primary Human CD8+ T Lymphocytes: A Role for Endogenous Granzyme B J. Immunol., April 1, 2006; 176(7): 3966 - 3977. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Y. Rudensky and D. J. Campbell In vivo sites and cellular mechanisms of T reg cell-mediated suppression J. Exp. Med., March 20, 2006; 203(3): 489 - 492. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Koonpaew, S. Shen, L. Flowers, and W. Zhang LAT-mediated signaling in CD4+CD25+ regulatory T cell development J. Exp. Med., January 23, 2006; 203(1): 119 - 129. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Yang, S. P. Huck, R. S. McHugh, I. F. Hermans, and F. Ronchese Perforin-dependent elimination of dendritic cells regulates the expansion of antigen-specific CD8+ T cells in vivo PNAS, January 3, 2006; 103(1): 147 - 152. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Paajanen, R. Korpela, T. Tuure, J. Honkanen, I. Jarvela, J. Ilonen, M. Knip, O. Vaarala, and J. Kokkonen Cow milk is not responsible for most gastrointestinal immune-like syndromes--evidence from a population-based study Am. J. Clinical Nutrition, December 1, 2005; 82(6): 1327 - 1335. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. T. Samy, L. A. Parker, C. P. Sharp, and K. S.K. Tung Continuous control of autoimmune disease by antigen-dependent polyclonal CD4+CD25+ regulatory T cells in the regional lymph node J. Exp. Med., September 19, 2005; 202(6): 771 - 781. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-F. Lu, D. C. Gondek, Z. A. Scott, and R. J. Noelle NF{kappa}B-Inducing Kinase Deficiency Results in the Development of a Subset of Regulatory T Cells, which Shows a Hyperproliferative Activity upon Glucocorticoid-Induced TNF Receptor Family-Related Gene Stimulation J. Immunol., August 1, 2005; 175(3): 1651 - 1657. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. L. King and B. M. Segal Cutting Edge: IL-12 Induces CD4+CD25- T Cell Activation in the Presence of T Regulatory Cells J. Immunol., July 15, 2005; 175(2): 641 - 645. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Pace, C. Pioli, and G. Doria IL-4 Modulation of CD4+CD25+ T Regulatory Cell-Mediated Suppression J. Immunol., June 15, 2005; 174(12): 7645 - 7653. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |